Markus Wittmann

822 total citations
20 papers, 560 citations indexed

About

Markus Wittmann is a scholar working on Clinical Psychology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Markus Wittmann has authored 20 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Clinical Psychology, 5 papers in Psychiatry and Mental health and 4 papers in Pharmacology. Recurrent topics in Markus Wittmann's work include Pharmacogenetics and Drug Metabolism (4 papers), Schizophrenia research and treatment (4 papers) and Tryptophan and brain disorders (3 papers). Markus Wittmann is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Schizophrenia research and treatment (4 papers) and Tryptophan and brain disorders (3 papers). Markus Wittmann collaborates with scholars based in Germany and Japan. Markus Wittmann's co-authors include Ekkehard Haen, Katharina Wenzel‐Seifert, Alexander Lenz, V. M. Braun, Bettina Hübner‐Liebermann, E. Stein, Peter M. Kreuzer, Berthold Langguth, Michael Landgrebe and Göran Hajak and has published in prestigious journals such as Physics Letters B, Journal of Chromatography B and Frontiers in Psychiatry.

In The Last Decade

Markus Wittmann

20 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Markus Wittmann Germany	11	166	136	106	67	66	20	560
Joo-Cheol Shim South Korea	15	110 0.7×	388 2.9×	36 0.3×	83 1.2×	91 1.4×	37	887
Chunyan Wang China	14	32 0.2×	104 0.8×	19 0.2×	48 0.7×	52 0.8×	36	543
Guoyuan Huang China	19	459 2.8×	20 0.1×	165 1.6×	15 0.2×	15 0.2×	51	944
M. Bruscoli Italy	6	45 0.3×	325 2.4×	41 0.4×	5 0.1×	14 0.2×	7	504
L. Pavan Italy	13	72 0.4×	27 0.2×	54 0.5×	71 1.1×	66 1.0×	26	541
V.K. Bhargava India	16	21 0.1×	41 0.3×	39 0.4×	55 0.8×	4 0.1×	65	590
Robert Miceli United States	13	10 0.1×	181 1.3×	18 0.2×	213 3.2×	79 1.2×	23	555
H. Sakuma Japan	16	40 0.2×	22 0.2×	767 7.2×	27 0.4×	5 0.1×	35	1.0k
S. de Jong France	3	17 0.1×	266 2.0×	11 0.1×	16 0.2×	86 1.3×	7	327
Cătălina Iliescu Gheorghiu Spain	11	11 0.1×	46 0.3×	97 0.9×	5 0.1×	92 1.4×	39	748

Countries citing papers authored by Markus Wittmann

Since Specialization

Citations

This map shows the geographic impact of Markus Wittmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Wittmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Wittmann more than expected).

Fields of papers citing papers by Markus Wittmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Wittmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Wittmann. The network helps show where Markus Wittmann may publish in the future.

Co-authorship network of co-authors of Markus Wittmann

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Wittmann. A scholar is included among the top collaborators of Markus Wittmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Wittmann. Markus Wittmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kreuzer, Peter M., Thomas C. Baghai, Rainer Rupprecht, et al.. (2020). SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat. Frontiers in Psychiatry. 11. 550–550. 13 indexed citations

Wittmann, Markus, Wolfgang Schreiber, Michael Landgrebe, & Göran Hajak. (2018). Störung zirkadianer Rhythmen im Kontext depressiver Erkrankungen. Fortschritte der Neurologie · Psychiatrie. 86(5). 308–318. 9 indexed citations

Haen, Ekkehard, et al.. (2012). Implementation of a Cost-Effective HPLC/UV Approach for Routine Medical Quantification of Memantine in Human Serum. Therapeutic Drug Monitoring. 34(6). 702–712. 6 indexed citations

Hübner‐Liebermann, Bettina, et al.. (2012). Recognizing and Treating Peripartum Depression. Deutsches Ärzteblatt international. 109(24). 419–24. 52 indexed citations

Neuner, Tanja, et al.. (2012). Acute psychiatric inpatient care: A cross-cultural comparison between two hospitals in Germany and Japan. International Journal of Social Psychiatry. 59(8). 771–781. 8 indexed citations

Kreuzer, Peter M., Michael Landgrebe, Markus Wittmann, et al.. (2011). Hypothermia Associated With Antipsychotic Drug Use: A Clinical Case Series and Review of Current Literature. The Journal of Clinical Pharmacology. 52(7). 1090–1097. 36 indexed citations

Kreuzer, Peter M., Michael Landgrebe, Markus Wittmann, et al.. (2011). Hypothermie unter Olanzapin. Der Nervenarzt. 83(5). 630–637. 7 indexed citations

Wenzel‐Seifert, Katharina, Markus Wittmann, & Ekkehard Haen. (2011). QTc Prolongation by Psychotropic Drugs and the Risk of Torsade de Pointes. Deutsches Ärzteblatt international. 108(41). 687–93. 169 indexed citations

Wittmann, Markus, et al.. (2011). Implementation of a cost-effective HPLC/UV-approach for medical routine quantification of donepezil in human serum. Journal of Chromatography B. 881-882. 1–11. 21 indexed citations

10.

Haen, Ekkehard, et al.. (2011). The dose-related reference range – a new tool for therapeutic drug monitoring (TDM). Pharmacopsychiatry. 44(6). 12 indexed citations

11.

Neuner, Tanja, et al.. (2011). Completed Suicides in 47 Psychiatric Hospitals in Germany – Results from the AGATE-Study. Pharmacopsychiatry. 44(7). 324–330. 14 indexed citations

12.

Wittmann, Markus, et al.. (2010). Verwirrtheitszustände als wichtige Arzneimittelwirkung. Therapeutische Umschau. 68(1). 27–33. 6 indexed citations

13.

Wittmann, Markus, et al.. (2010). Individual clearance and therapeutic drug monitoring of quetiapine in clinical practice.. PubMed. 31(2). 203–7. 14 indexed citations

14.

Wittmann, Markus, et al.. (2009). Folgen neu erkannter Arzneimittelrisiken auf die Antipsychotikaverordnung bei Demenzerkrankten. Psychiatrische Praxis. 37(2). 68–70. 2 indexed citations

15.

Haen, Ekkehard, et al.. (2008). Wirkstoffkonzentrations-bestimmungen zur Therapieleitung : Ergänzung therapeutischer Referenzbereiche durch dosisbezogene Referenzbereiche. Der Nervenarzt. 79(5). 558–566. 4 indexed citations

16.

Haen, Ekkehard, et al.. (2008). Wirkstoffkonzentrationsbestimmungen zur Therapieleitung. Der Nervenarzt. 79(5). 558–566. 14 indexed citations

17.

Braun, V. M., Alexander Lenz, & Markus Wittmann. (2006). Nucleon form factors in QCD. Physical review. D. Particles, fields, gravitation, and cosmology. 73(9). 125 indexed citations

18.

Ibach, Bernd, et al.. (2004). Tau-assoziierte genetische Polymorphismen bei frontotemporaler Demenz. PubMed. 31. 55–57. 1 indexed citations

19.

Lenz, Alexander, Markus Wittmann, & E. Stein. (2004). Improved light-cone sum rules for the electromagnetic form factors of the nucleon. Physics Letters B. 581(3-4). 199–206. 42 indexed citations

20.

Schmauß, Max, et al.. (1985). Clinical Investigation on the Importance of NE-Reuptake Inhibition for Antidepressive Efficacy: Oxaprotiline versus its R-enantiomer CGP 12-103/A. Pharmacopsychiatry. 18(1). 86–87. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact